Clinical effects of low‐dose esketamine for anaesthesia induction in the elderly: A randomized controlled trial
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Pharmacy and Therapeutics"
DOI: 10.1111/jcpt.13604
Abstract: Esketamine is an N‐methyl‐D‐aspartic acid (NMDA) receptor antagonist, which has stronger sedative and analgesic effects and fewer adverse events than ketamine. The effects of low‐dose esketamine on haemodynamics and postoperative quality of recovery in elderly… read more here.
Keywords: induction elderly; effects low; anaesthesia induction; dose esketamine ... See more keywords